BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Amitani M, Asakawa A, Amitani H, Inui A. Control of food intake and muscle wasting in cachexia. The International Journal of Biochemistry & Cell Biology 2013;45:2179-85. [DOI: 10.1016/j.biocel.2013.07.016] [Cited by in Crossref: 25] [Cited by in F6Publishing: 26] [Article Influence: 2.8] [Reference Citation Analysis]
Number Citing Articles
1 Inácio Pinto N, Carnier J, Oyama LM, Otoch JP, Alcântara PS, Tokeshi F, Nascimento CM. Cancer as a Proinflammatory Environment: Metastasis and Cachexia. Mediators Inflamm 2015;2015:791060. [PMID: 26508818 DOI: 10.1155/2015/791060] [Cited by in Crossref: 30] [Cited by in F6Publishing: 36] [Article Influence: 4.3] [Reference Citation Analysis]
2 Penafuerte CA, Gagnon B, Sirois J, Murphy J, MacDonald N, Tremblay ML. Identification of neutrophil-derived proteases and angiotensin II as biomarkers of cancer cachexia. Br J Cancer 2016;114:680-7. [PMID: 26954714 DOI: 10.1038/bjc.2016.3] [Cited by in Crossref: 35] [Cited by in F6Publishing: 34] [Article Influence: 5.8] [Reference Citation Analysis]
3 Dingemans AC, de Vos-geelen J, Langen R, Schols AM. Phase II drugs that are currently in development for the treatment of cachexia. Expert Opinion on Investigational Drugs 2014;23:1655-69. [DOI: 10.1517/13543784.2014.942729] [Cited by in Crossref: 29] [Cited by in F6Publishing: 25] [Article Influence: 3.6] [Reference Citation Analysis]
4 Kordes M, Larsson L, Engstrand L, Löhr JM. Pancreatic cancer cachexia: three dimensions of a complex syndrome. Br J Cancer 2021;124:1623-36. [PMID: 33742145 DOI: 10.1038/s41416-021-01301-4] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
5 Freemark M. Metabolomics in Nutrition Research: Biomarkers Predicting Mortality in Children with Severe Acute Malnutrition. Food Nutr Bull 2015;36:S88-92. [DOI: 10.1177/15648265150361s114] [Cited by in Crossref: 27] [Cited by in F6Publishing: 10] [Article Influence: 3.9] [Reference Citation Analysis]
6 Rizzi M, Mazzuoli S, Regano N, Inguaggiato R, Bianco M, Leandro G, Bugianesi E, Noè D, Orzes N, Pallini P, Petroni ML, Testino G, Guglielmi FW. Undernutrition, risk of malnutrition and obesity in gastroenterological patients: A multicenter study. World J Gastrointest Oncol 2016; 8(7): 563-572 [PMID: 27559436 DOI: 10.4251/wjgo.v8.i7.563] [Cited by in CrossRef: 4] [Cited by in F6Publishing: 5] [Article Influence: 0.7] [Reference Citation Analysis]
7 Nishikawa H, Goto M, Fukunishi S, Asai A, Nishiguchi S, Higuchi K. Cancer Cachexia: Its Mechanism and Clinical Significance. Int J Mol Sci 2021;22:8491. [PMID: 34445197 DOI: 10.3390/ijms22168491] [Reference Citation Analysis]
8 Murphy CF, le Roux CW. The Neurobiological Impact of Ghrelin Suppression after Oesophagectomy. Int J Mol Sci 2016;18:E35. [PMID: 28035969 DOI: 10.3390/ijms18010035] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
9 Hao L, Sheng Z, Potian J, Deak A, Rohowsky-Kochan C, Routh VH. Lipopolysaccharide (LPS) and tumor necrosis factor alpha (TNFα) blunt the response of Neuropeptide Y/Agouti-related peptide (NPY/AgRP) glucose inhibited (GI) neurons to decreased glucose. Brain Res 2016;1648:181-92. [PMID: 27473896 DOI: 10.1016/j.brainres.2016.07.035] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 1.7] [Reference Citation Analysis]
10 Ewaschuk JB, Almasud A, Mazurak VC. Role of n-3 fatty acids in muscle loss and myosteatosis. Appl Physiol Nutr Metab 2014;39:654-62. [PMID: 24869970 DOI: 10.1139/apnm-2013-0423] [Cited by in Crossref: 24] [Cited by in F6Publishing: 23] [Article Influence: 3.0] [Reference Citation Analysis]
11 Narsale AA, Carson JA. Role of interleukin-6 in cachexia: therapeutic implications. Curr Opin Support Palliat Care 2014;8:321-7. [PMID: 25319274 DOI: 10.1097/SPC.0000000000000091] [Cited by in Crossref: 99] [Cited by in F6Publishing: 69] [Article Influence: 14.1] [Reference Citation Analysis]
12 Uto NS, Amitani H, Atobe Y, Sameshima Y, Sakaki M, Rokot N, Ataka K, Amitani M, Inui A. Herbal Medicine Ninjin'yoeito in the Treatment of Sarcopenia and Frailty. Front Nutr 2018;5:126. [PMID: 30619872 DOI: 10.3389/fnut.2018.00126] [Cited by in Crossref: 14] [Cited by in F6Publishing: 11] [Article Influence: 3.5] [Reference Citation Analysis]
13 Shibasaki K, Yamada S, Akishita M, Ogawa S. Plasma Leptin Concentration and Sympathetic Nervous Activity in Older Adults With Physical Dysfunction. J Endocr Soc 2018;2:1040-9. [PMID: 30187016 DOI: 10.1210/js.2018-00104] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
14 Inoue H, Kosuga T, Kubota T, Konishi H, Shiozaki A, Okamoto K, Fujiwara H, Otsuji E. Significance of a preoperative systemic immune-inflammation index as a predictor of postoperative survival outcomes in gastric cancer. World J Surg Oncol 2021;19:173. [PMID: 34118953 DOI: 10.1186/s12957-021-02286-3] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
15 Endo T, Momoki C, Yamaoka M, Hachino S, Iwatani S, Kiyota S, Tanaka H, Habu D. Validation of Skeletal Muscle Volume as a Nutritional Assessment in Patients With Gastric or Colorectal Cancer Before Radical Surgery. J Clin Med Res 2017;9:844-59. [PMID: 28912921 DOI: 10.14740/jocmr3129w] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 1.2] [Reference Citation Analysis]
16 Ferioli M, Zauli G, Martelli AM, Vitale M, McCubrey JA, Ultimo S, Capitani S, Neri LM. Impact of physical exercise in cancer survivors during and after antineoplastic treatments. Oncotarget 2018;9:14005-34. [PMID: 29568412 DOI: 10.18632/oncotarget.24456] [Cited by in Crossref: 31] [Cited by in F6Publishing: 23] [Article Influence: 7.8] [Reference Citation Analysis]
17 Ezeoke CC, Morley JE. Pathophysiology of anorexia in the cancer cachexia syndrome. J Cachexia Sarcopenia Muscle 2015;6:287-302. [PMID: 26675762 DOI: 10.1002/jcsm.12059] [Cited by in Crossref: 92] [Cited by in F6Publishing: 78] [Article Influence: 13.1] [Reference Citation Analysis]
18 Kasprzak A. The Role of Tumor Microenvironment Cells in Colorectal Cancer (CRC) Cachexia. Int J Mol Sci 2021;22:1565. [PMID: 33557173 DOI: 10.3390/ijms22041565] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 4.0] [Reference Citation Analysis]
19 Amitani M, Amitani H, Sloan RA, Suzuki H, Sameshima N, Asakawa A, Nerome Y, Owaki T, Inui A, Hoshino E. The translational aspect of complementary and alternative medicine for cancer with particular emphasis on Kampo. Front Pharmacol 2015;6:150. [PMID: 26300773 DOI: 10.3389/fphar.2015.00150] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 1.7] [Reference Citation Analysis]
20 Peixoto da Silva S, Santos JMO, Costa E Silva MP, Gil da Costa RM, Medeiros R. Cancer cachexia and its pathophysiology: links with sarcopenia, anorexia and asthenia. J Cachexia Sarcopenia Muscle 2020;11:619-35. [PMID: 32142217 DOI: 10.1002/jcsm.12528] [Cited by in Crossref: 35] [Cited by in F6Publishing: 35] [Article Influence: 17.5] [Reference Citation Analysis]
21 Martín AI, Priego T, López-calderón A. Hormones and Muscle Atrophy. In: Xiao J, editor. Muscle Atrophy. Singapore: Springer; 2018. pp. 207-33. [DOI: 10.1007/978-981-13-1435-3_9] [Cited by in Crossref: 19] [Cited by in F6Publishing: 16] [Article Influence: 4.8] [Reference Citation Analysis]
22 Pastor-Cavada E, Pardo LM, Kandil D, Torres-Fuentes C, Clarke SL, Shaban H, McGlacken GP, Schellekens H. A Novel Non-Peptidic Agonist of the Ghrelin Receptor with Orexigenic Activity In vivo. Sci Rep 2016;6:36456. [PMID: 27819353 DOI: 10.1038/srep36456] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 1.5] [Reference Citation Analysis]
23 Zhang X, Yang T, Wang J, Feng M, Hou Y, Shen Y, Chen L. Elevated circulating ghrelin in patients with COPD: A meta-analysis. Chron Respir Dis 2018;15:365-73. [PMID: 29486584 DOI: 10.1177/1479972318757468] [Cited by in Crossref: 1] [Article Influence: 0.3] [Reference Citation Analysis]
24 Amitani M, Amitani H, Cheng KC, Kairupan TS, Sameshima N, Shimoshikiryo I, Mizuma K, Rokot NT, Nerome Y, Owaki T, Asakawa A, Inui A. The Role of Ghrelin and Ghrelin Signaling in Aging. Int J Mol Sci 2017;18:E1511. [PMID: 28704966 DOI: 10.3390/ijms18071511] [Cited by in Crossref: 18] [Cited by in F6Publishing: 15] [Article Influence: 3.6] [Reference Citation Analysis]
25 Torres-Fuentes C, Pastor-Cavada E, Cano R, Kandil D, Shanahan R, Juan R, Shaban H, McGlacken GP, Schellekens H. Quinolones Modulate Ghrelin Receptor Signaling: Potential for a Novel Small Molecule Scaffold in the Treatment of Cachexia. Int J Mol Sci 2018;19:E1605. [PMID: 29848961 DOI: 10.3390/ijms19061605] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 1.5] [Reference Citation Analysis]
26 Cichello SA, Weisinger RS, Schuijers J, Jois M. 1-Sarcosine-angiotensin II infusion effects on food intake, weight loss, energy expenditure, and skeletal muscle UCP3 gene expression in a rat model. J Cachexia Sarcopenia Muscle 2014;5:239-46. [PMID: 24614996 DOI: 10.1007/s13539-014-0133-2] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 1.3] [Reference Citation Analysis]